<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>24</Volume>
				<Issue>3</Issue>
				<PubDate PubStatus="epublish">
					<Year>2023</Year>
					<Month>03</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Protective Effect of Adenosine Triphosphate against 5-Fluorouracil-Induced Oxidative Ovarian Damage in vivo</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1007</FirstPage>
			<LastPage>1013</LastPage>
			<ELocationID EIdType="pii">90524</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2023.24.3.1007</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Mehmet </FirstName>
					<LastName>Ozer</LastName>
<Affiliation>Department of Obstetrics and Gynecology, Izmir Tepecik Regional Training Research Hospital, Izmir, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Sefa </FirstName>
					<LastName>Ince</LastName>
<Affiliation>Department
of Obstetrics and Gynecology, Regional Training Research Hospital, Erzurum, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Durdu </FirstName>
					<LastName>Altuner</LastName>
<Affiliation>Department of Pharmacology,
Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Zeynep </FirstName>
					<LastName>Suleyman</LastName>
<Affiliation>Department of Pharmacology,
Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Betul </FirstName>
					<LastName>Cicek</LastName>
<Affiliation>Department of Physiology, Faculty of
Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Mine </FirstName>
					<LastName>Gulaboglu</LastName>
<Affiliation>Department of Biochemistry, Faculty of Pharmacy, Ataturk University, Erzurum, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Behzad </FirstName>
					<LastName>Mokhtare</LastName>
<Affiliation>Department of Pathology, Faculty of Veterinary, Ataturk University, Erzurum, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Cebrail </FirstName>
					<LastName>Gursul</LastName>
<Affiliation>Department of Physiology, Faculty of
Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey.</Affiliation>

</Author>
<Author>
					<FirstName>Halis </FirstName>
					<LastName>Suleyman</LastName>
<Affiliation>Department of Pharmacology,
Faculty of Medicine, Erzincan Binali Yildirim University, Erzincan, Turkey.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2022</Year>
					<Month>10</Month>
					<Day>25</Day>
				</PubDate>
			</History>
		<Abstract>Objective: The aim of our study was to analyze the effect of ATP on possible ovarian damage of 5-FU in rats. Methods: The animals were divided to three groups; healthy group (HG), 5-FU alone group (FUG) and ATP+5-FU administered group (AFU). The ATP 4 mg/kg was injected intraperitoneally (IP) into the AFU group. The same volume of saline (0.9% NaCl) as the solvent was administered intraperitoneally to the HG and FUG groups. One hour after administering ATP and solvent, 5-FU 100 mg/kg was injected intraperitoneally to the animals in the AFU and FUG groups. ATP was administered to the animals once a day for 10 days. On the 1st, 3rd and 5th days of 5-FU, one dose (total of 3 doses) was administered. On day 10, the animals were euthanasia with high-dose anaesthesia and ovarian tissues were removed. The removed ovaries were analyzed biochemically andhistopathological. Result: ATP significantly suppressed both the increase in MDA and IL-6 levels, and the decrease in tGSH, SOD and CAT levels. Treatment with ATP significantly suppressed the severe vacuolization and primordial follicle degeneration induced by 5-FU in our study. Conclusion: ATP was possible to be useful for the treatment of 5-FU-induced ovarian damage.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">5-fluorouracil</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Adenosine triphosphate</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Inflammation</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ovarian</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Rat</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_90524_3d63462dac20b6c60af61e664309e521.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
